Searched for
GLAXOSMITHKLINE MD
GlaxoSmithKline Pharma Q1 Results: Net profit rises 11% to Rs 132 crDespite the strong external headwinds, GSK remains focused on delivering best-in-class competitive performance and driving operational effi...- GlaxoSmithKline Pharma names Bhushan Akshikar as new Managing DirectorBefore joining GSK, Akshikar spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care busine...
- GSK India appoints Bhushan Akshikar as managing directorAkshikar with over 26 years experience within the pharmaceutical industry, joined GSK India in September 2011 to lead the specialty and com...
- Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore"Our results reflect good momentum across general medicines and vaccines during the quarter. We have delivered strong underlying growth wit...
- GlaxoSmithKline Pharma Q4 results: Reports net profit of Rs 14 crIts consolidated revenue from operations stood at Rs 813.75 crore for the quarter under consideration. It was Rs 775.80 crore a year ago
- GlaxoSmithKline Pharmaceuticals Q3 results: Reports net profit of Rs 157 crRevenue from operations rose by 10 per cent to Rs 857.20 crore during the third quarter as against Rs 778.59 crore in the year-ago period, ...
- GlaxoSmithKline Pharma Q2 results: Net profit declines 85% to Rs 76 crConsolidated revenue from operations of the company stood at Rs 879.32 crore for the quarter under consideration. It was Rs 882.02 crore fo...
- GlaxoSmithKline Pharma Q1 results: Net profit declines 2.38% to Rs 111 crThe company had posted a net profit of Rs 113.54 crore in the corresponding period previous fiscal, GlaxoSmithKline Pharmaceuticals said...
- GlaxoSmithKline Pharma Q4 results: Net profit declines 6% to Rs 138 croreThe company had posted a net profit of Rs 146.81 crore for the same period previous fiscal.
- GlaxoSmithKline Pharma Q3 profit up 26% at Rs 113 croreRevenue from operations of the company stood at Rs 825.35 crore for the quarter.
- Focus on 20 key brands to drive growth: GlaxoSmithKline pharmaceuticalsAs part of its growth plans the company is also planning to aggressively expand its field force.
- GlaxoSmithKline Consumer Q1 net jumps 52% to Rs 200 croreThe company had reported a net profit of Rs 132.23 crore for the same period previous fiscal.
- Accumulate GlaxoSmithKline Consumer Healthcare, target Rs 6,797: Prabhudas LilladherAccumulate GlaxoSmithKline Consumer Healthcare Ltd. at a price target of Rs 6797.0 .
- GSK Consumer Q3 net up 20%The company had reported a net profit of Rs 136.4 crore for the October-December period a year ago. The company’s revenue from operations w...
- GlaxoSmithKline net up 18 pc at Rs 136.74 croreGlaxoSmithKline Pharmaceuticals said its net profit rose by 18.18 per cent to Rs 136.74 crore for the quarter ended December 31, 2011.
- Oberoi Group in talks to buy 50% in south Mumbai project held by ICICI VentureThe Oberoi Realty Group is in talks to buy the 50% stake held by ICICI Venture in a residential project in south Mumbai.
- GlaxoSmithKline Consumer Q2 net up 15% at Rs 82.46 crGlaxoSmithKline Consumer Healthcare Limited (GSKCH) on Monday said its has registered a 15 per cent jump in its net profit to Rs 82.46 cror...
- GlaxoSmithKline FY10 net profit up 10.37 pc to Rs 560.57 crGlaxoSmithKline Pharmaceuticals today said its consolidated net profit rose by 10.37 per cent to Rs 560.57 crore for the year ended Decembe...
- Buy Glaxo and Cipla: Sandeep WagleWe are having a target of somewhere around 335 in Cipla which is around 5% to 7% from the current levels.
- GlaxoSmithKline Pharma to launch more vaccines in IndiaDrug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
Load More
